PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY

Oncotype Dx ◽

Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis

Health Technology Assessment ◽

10.3310/hta17440 ◽

2013 ◽

Vol 17 (44) ◽

Cited By ~ 50

Author(s):

S Ward ◽

A Scope ◽

R Rafia ◽

A Pandor ◽

S Harnan ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Systematic Review ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Gene Expression Profiling ◽

Expression Profiling ◽

Cancer Management ◽

Effectiveness Analysis ◽

Breast Cancer Management

Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

PharmacoEconomics ◽

10.1007/s40273-014-0227-x ◽

2014 ◽

Vol 33 (2) ◽

pp. 179-190 ◽

Cited By ~ 13

Author(s):

Patricia R. Blank ◽

Martin Filipits ◽

Peter Dubsky ◽

Florian Gutzwiller ◽

Michael P. Lux ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cost Effectiveness ◽

Cancer Patients ◽

Early Breast Cancer ◽

Gene Expression Signature ◽

Breast Cancer Patients ◽

Prognostic Gene ◽

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

BMC Cancer ◽

10.1186/s12885-017-3603-z ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 5

Author(s):

Beate Jahn ◽

Ursula Rochau ◽

Christina Kurzthaler ◽

Michael Hubalek ◽

Rebecca Miksad ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Risk Group ◽

Personalized Treatment ◽

Specific Cost ◽

Effectiveness Analysis ◽

Prognostic Tests

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

The Breast ◽

10.1016/s0960-9776(07)70240-0 ◽

2007 ◽

Vol 16 ◽

pp. S64

Author(s):

B.L. Rapoport ◽

S.D. Moodley ◽

C. Jacobs ◽

R. Pienaar ◽

S. Fourie ◽

...

Keyword(s):

Breast Cancer ◽

South Africa ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Node Positive ◽

Cost-Effectiveness Analysis Of The Use Of Oncotype Dx To Guide Adjuvant Chemotherapy Decisions In Breast Cancer Patients In Mexico

Value in Health ◽

10.1016/j.jval.2013.03.684 ◽

2013 ◽

Vol 16 (3) ◽

pp. A140

Author(s):

J. Plun-Favreau ◽

S. Suarez ◽

H. Chivardy ◽

L. Pozo

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE

Value in Health ◽

10.1016/s1098-3015(10)67250-6 ◽

2005 ◽

Vol 8 (6) ◽

pp. A36-A37 ◽

Cited By ~ 1

Author(s):

H Miadi-Fargier ◽

C Le Pen ◽

MC Woronoff-Lemsi ◽

JP Guastalla ◽

X Pivot ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Effectiveness Analysis ◽

Cancer Cost

58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.072 ◽

2021 ◽

Vol 32 ◽

pp. S45

Author(s):

X. Guan ◽

H-C. Li ◽

Q-J. Chen ◽

B. Hua ◽

J-J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Chinese Patients ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1909478 ◽

2021 ◽

pp. 1-10

Author(s):

Carlos Henrique Botelho ◽

Maria Del Pilar Estevez-Diz ◽

Alessandro Gonçalves Campolina

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA

Value in Health ◽

10.1016/j.jval.2019.09.048 ◽

2019 ◽

Vol 22 ◽

pp. S405-S406

Author(s):

X. Guan ◽

H. Li ◽

Q. Chen ◽

C. Hao ◽

J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

High Risk ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Her2 Positive ◽

Risk Of Recurrence ◽

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

Cancer ◽

10.1002/cncr.29621 ◽

2015 ◽

Vol 121 (22) ◽

pp. 4062-4070 ◽

Cited By ~ 19

Author(s):

Arnold L. Potosky ◽

Suzanne C. O'Neill ◽

Claudine Isaacs ◽

Huei-Ting Tsai ◽

Calvin Chao ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Adjuvant Chemotherapy ◽

Gene Expression Profiling ◽

Cancer Patients ◽

Expression Profiling ◽

Population Based ◽

Breast Cancer Patients ◽

Population Based Study